Literature DB >> 1466661

Differential regulation of hepatic apolipoprotein A-I and A-II gene expression by thyroid hormone in rat liver.

W Strobl1, L Chan, W Patsch.   

Abstract

Apolipoproteins A-I and A-II (apo A-I, apo A-II) are major protein components of high density lipoproteins. Thyroid hormone has a differential effect on the expression of the apo A-I and apo A-II genes in rat liver. Apo A-I gene expression is stimulated by thyroid hormone, whereas apo A-II mRNA abundance is decreased in chronic hyperthyroidism. To determine the regulatory steps involved in this differential effect of thyroid hormone on hepatic apo A-I and apo A-II gene expression, we studied the effect of short term and chronic hyperthyroidism on apo A-I and apo A-II gene transcription rates, nuclear RNA abundance and total cellular mRNA levels. After a single receptor saturating dose of L-triiodothyronine (T3) apo A-II gene transcription was transiently increased to 164% +/- 13% of basal values (P < 0.05) without affecting nuclear apo A-II RNA abundance. Apo A-I gene transcription, however, increased to 158% +/- 8% of baseline levels (P < 0.05) and remained elevated for at least 24 h. Nuclear and total cellular apo A-I mRNA increased more than expected from the increased transcription rate suggesting nuclear RNA stabilization and/or more efficient processing of the primary transcripts. In chronic hyperthyroidism, total cellular apo A-II mRNA abundance decreased to 62% +/- 18% (P < 0.05) and apo A-II gene transcription and apo A-II nuclear RNA were moderately reduced. By contrast, apo A-I nuclear and total cellular RNA were increased several fold by post-transcriptional mechanisms, whereas apo A-I gene transcription was drastically decreased. We conclude that the apo A-I and apo A-II genes in rat liver respond differently to both acute and chronic hyperthyroidism and that their expression is regulated at transcriptional and posttranscriptional levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466661     DOI: 10.1016/0021-9150(92)90129-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Type 1 Deiodinase Regulates ApoA-I Gene Expression and ApoA-I Synthesis Independent of Thyroid Hormone Signaling.

Authors:  Jing Liu; Antonio Hernandez-Ono; Mark J Graham; Valerie Anne Galton; Henry N Ginsberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-05       Impact factor: 8.311

2.  Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.

Authors:  R A Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

Review 3.  High density lipoprotein, apolipoprotein A-I, and coronary artery disease.

Authors:  R A Srivastava; N Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

4.  Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor beta heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and upstream stimulatory factor 2a.

Authors:  Eudoxia Hatzivassiliou; George Koukos; Agnes Ribeiro; Vassilis Zannis; Dimitris Kardassis
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

5.  Genetic resistance to DEHP-induced transgenerational endocrine disruption.

Authors:  Ludwig Stenz; Rita Rahban; Julien Prados; Serge Nef; Ariane Paoloni-Giacobino
Journal:  PLoS One       Date:  2019-06-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.